Research ArticleArticle
Use of Pharmacogenetics, Enzymatic Phenotyping, and Metabolite Monitoring to Guide Treatment with Azathioprine in Patients with Systemic Lupus Erythematosus
ANCA D. ASKANASE, DANIEL J. WALLACE, MICHAEL H. WEISMAN, CHUNG-E TSENG, LANA BERNSTEIN, H. MICHAEL BELMONT, ERNEST SEIDMAN, MARIKO ISHIMORI, PETER M. IZMIRLY and JILL P. BUYON
The Journal of Rheumatology January 2009, 36 (1) 89-95; DOI: https://doi.org/10.3899/jrheum.070968
ANCA D. ASKANASE
DANIEL J. WALLACE
MICHAEL H. WEISMAN
CHUNG-E TSENG
LANA BERNSTEIN
H. MICHAEL BELMONT
ERNEST SEIDMAN
MARIKO ISHIMORI
PETER M. IZMIRLY
In this issue
The Journal of Rheumatology
Vol. 36, Issue 1
1 Jan 2009
Use of Pharmacogenetics, Enzymatic Phenotyping, and Metabolite Monitoring to Guide Treatment with Azathioprine in Patients with Systemic Lupus Erythematosus
ANCA D. ASKANASE, DANIEL J. WALLACE, MICHAEL H. WEISMAN, CHUNG-E TSENG, LANA BERNSTEIN, H. MICHAEL BELMONT, ERNEST SEIDMAN, MARIKO ISHIMORI, PETER M. IZMIRLY, JILL P. BUYON
The Journal of Rheumatology Jan 2009, 36 (1) 89-95; DOI: 10.3899/jrheum.070968
Use of Pharmacogenetics, Enzymatic Phenotyping, and Metabolite Monitoring to Guide Treatment with Azathioprine in Patients with Systemic Lupus Erythematosus
ANCA D. ASKANASE, DANIEL J. WALLACE, MICHAEL H. WEISMAN, CHUNG-E TSENG, LANA BERNSTEIN, H. MICHAEL BELMONT, ERNEST SEIDMAN, MARIKO ISHIMORI, PETER M. IZMIRLY, JILL P. BUYON
The Journal of Rheumatology Jan 2009, 36 (1) 89-95; DOI: 10.3899/jrheum.070968